Longitudinal post-shunt outcomes in idiopathic normal pressure hydrocephalus with and without comorbid Alzheimer's disease.

cognitive dysfunction dementia executive function neurodegenerative diseases neurosurgery neurosurgical procedures

Journal

Journal of the International Neuropsychological Society : JINS
ISSN: 1469-7661
Titre abrégé: J Int Neuropsychol Soc
Pays: England
ID NLM: 9503760

Informations de publication

Date de publication:
10 2023
Historique:
medline: 12 9 2023
pubmed: 15 12 2022
entrez: 14 12 2022
Statut: ppublish

Résumé

Alzheimer's disease (AD) is highly comorbid with idiopathic normal pressure hydrocephalus (iNPH) and may diminish the benefits of shunting; however, findings in this area are mixed. We examined postoperative outcomes, with emphases on cognition and utilization of novel scoring procedures to enhance sensitivity. Using participant data from an iNPH outcome study at Butler Hospital, a mixed effect model examined main and interaction effects of time since surgery (baseline, 3 months, 12 months, and 24-60 months) and AD comorbidity (20 iNPH and 11 iNPH+AD) on activities of daily living (ADLs) and iNPH symptoms. Regression modeling explored whether baseline variables predicted improvements 3 months postoperatively. There were no group differences in gait, incontinence, and global cognition over time, and neither group showed changes in ADLs. Cognitive differences were observed postoperatively; iNPH patients showed stable improvements in working memory ( iNPH + AD may be linked with greater declines in aspects of executive functioning postoperatively relative to iNPH alone. While baseline AD pathology may not prognosticate shunt response, younger age appears linked with postsurgical cognitive improvement, and utilizing both brief and comprehensive cognitive measures may help predict improved incontinence. These results illustrate the potential benefits of surgery and inform postoperative expectations for those with iNPH + AD.

Identifiants

pubmed: 36515069
pii: S1355617722000868
doi: 10.1017/S1355617722000868
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

751-762

Auteurs

Dov Gold (D)

Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Memory and Aging Program, Butler Hospital, Providence, RI, USA.
Department of Clinical Psychology, William James College, Newton, MA, USA.

Caroline Wisialowski (C)

Memory and Aging Program, Butler Hospital, Providence, RI, USA.

Irene Piryatinsky (I)

Neuropsychological Assessment Clinic, Brighton, MA, USA.

Paul Malloy (P)

Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Memory and Aging Program, Butler Hospital, Providence, RI, USA.

Stephen Correia (S)

Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Memory and Aging Program, Butler Hospital, Providence, RI, USA.

Stephen Salloway (S)

Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Memory and Aging Program, Butler Hospital, Providence, RI, USA.
Department of Neurology, Warren Alpert Medical School of Brown University, Providence, RI, USA.

Petra Klinge (P)

Department of Neurosurgery, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Lifespan Physician Group, Rhode Island Hospital, Providence, RI, USA.

Charles E Gaudet (CE)

Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Memory and Aging Program, Butler Hospital, Providence, RI, USA.

Madison Niermeyer (M)

Department of Physical Medicine & Rehabilitation, University of Utah, Salt Lake City, UT, USA.

Athene Lee (A)

Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Memory and Aging Program, Butler Hospital, Providence, RI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH